Takip et
Peter Katelaris
Peter Katelaris
Associate Professor University of Sydney, Concord Hospital Australia
sydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
KM Fock, P Katelaris, K Sugano, TL Ang, R Hunt, NJ Talley, SK Lam, ...
Journal of gastroenterology and hepatology 24 (10), 1587-1600, 2009
7582009
Asia‐Pacific consensus on the management of gastroesophageal reflux disease: update
KM Fock, NJ Talley, R Fass, KL Goh, P Katelaris, R Hunt, M Hongo, ...
Journal of gastroenterology and hepatology 23 (1), 8-22, 2008
2972008
Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis.
CT Loy, LM Irwig, PH Katelaris, NJ Talley
American Journal of Gastroenterology (Springer Nature) 91 (6), 1996
2801996
Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
GJH Park, BP Lin, MC Ngu, DB Jones, PH Katelaris
Journal of gastroenterology and hepatology 15 (4), 386-390, 2000
2722000
World gastroenterology organisation global guidelines: GERD global perspective on gastroesophageal reflux disease
R Hunt, D Armstrong, P Katelaris, M Afihene, A Bane, S Bhatia, MH Chen, ...
Journal of clinical gastroenterology 51 (6), 467-478, 2017
2682017
CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement
PG Gibson, AB Chang, NJ Glasgow, PW Holmes, P Katelaris, AS Kemp, ...
Medical Journal of Australia 192 (5), 265-271, 2010
2452010
Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review
BA Adelstein, P Macaskill, SF Chan, PH Katelaris, L Irwig
BMC gastroenterology 11, 1-10, 2011
2312011
Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
PH Katelaris, F Seow, BP Lin, J Napoli, MC Ngu, DB Jones
Gut 34 (8), 1032-1037, 1993
2311993
Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus
KM Fock, N Talley, KL Goh, K Sugano, P Katelaris, G Holtmann, ...
Gut 65 (9), 1402-1415, 2016
2232016
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study
PH Katelaris, GM Forbes, NJ Talley, B Crotty, FTAPH Pylori, S Group
Gastroenterology 123 (6), 1763-1769, 2002
2172002
Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views
CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ...
Journal of Crohn's and Colitis 7 (6), e206-e213, 2013
2062013
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study
J Labenz, D Armstrong, K Lauritsen, P Katelaris, S Schmidt, K Schütze, ...
Alimentary pharmacology & therapeutics 21 (6), 739-746, 2005
1902005
Lactobacilli to prevent traveler's diarrhea?
PH Katelaris, I Salam, MJG Farthing
New England Journal of Medicine 333 (20), 1360-1361, 1995
1871995
The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach
ZW Zhang, SE Patchett, D Perrett, PH Katelaris, P Domizio, MJG Farthing
Gut 43 (3), 322-326, 1998
1861998
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
JM Scheiman, PJ Devereaux, J Herlitz, PH Katelaris, A Lanas, ...
Heart 97 (10), 797-802, 2011
1782011
Randomised trial of single-dose ciprofloxacin for travellers' diarrhoea
I Salam, P Katelaris, MJG Farthing, S Leigh-Smith
The Lancet 344 (8936), 1537-1539, 1994
1731994
The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper
N Vakil, SV Van Zanten, P Kahrilas, J Dent, R Jones
Zeitschrift Fur Gastroenterologie 45 (11), 1125-1140, 2007
1662007
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection
H Mitchell, P Katelaris
The Medical Journal of Australia 204 (10), 376-380, 2016
1282016
Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease
CP Selinger, J Eaden, DB Jones, P Katelaris, G Chapman, C McDonald, ...
Inflammatory bowel diseases 19 (10), 2199-2206, 2013
1252013
Patients' knowledge of pregnancy‐related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’)
CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ...
Alimentary pharmacology & therapeutics 36 (1), 57-63, 2012
1182012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20